Results 291 to 300 of about 98,851 (337)

Prognostic Value of Neutrophil-Lymphocyte Ratio Change After Short-Term Chemotherapy in <i>De Novo</i> Stage IV Breast Cancer Patients. [PDF]

open access: yesJ Breast Cancer
Shin H   +12 more
europepmc   +1 more source

Dietary Protein Restriction Ameliorates Cardiac Inflammaging via AMPK‐ULK1‐Mediated Mitochondrial Quality Control

open access: yesAging Cell, Volume 25, Issue 2, February 2026.
Dietary protein restriction protects the aging heart in the context of obesity by limiting mitochondrial DNA leakage and suppressing cGAS–STING‐driven inflammation. Through AMPK–ULK1‐dependent mitophagy, protein restriction restores mitochondrial quality control, reduces cardiac remodeling, and preserves metabolic homeostasis during obesity‐associated ...
Wagner S. Dantas   +8 more
wiley   +1 more source

Alterations in Gut Microbiota and Metabolism in Cirrhotic Portal Hypertension: Implications for Disease Progression

open access: yesAlimentary Pharmacology &Therapeutics, Volume 63, Issue 4, Page 538-556, February 2026.
In‐depth multiomics analyses revealed that the gut microbiota in patients with CPH is dysbiotic. Altered gut microbiota plays an important role in the progression of CPH and affects the host's arginine metabolism to promote arginine biosynthesis. The pro‐inflammatory effects of certain gut bacteria induce iNOS expression, which together act on the ...
Qun Zhang   +15 more
wiley   +1 more source

Exploring fern pathosystems and immune receptors to bridge gaps in plant immunity. [PDF]

open access: yesBMC Biol
Castel B   +6 more
europepmc   +1 more source

Prognostic Impact of DPP4 Inhibitors on Systemic Drug Therapy for Advanced Kidney Cancer Patients

open access: yesCancer Science, Volume 117, Issue 2, Page 468-475, February 2026.
Treatment with DPP4 inhibitors was identified as a favorable prognostic factor in patients with advanced RCC. A more substantial degree of tumor shrinkage was observed in the subgroup of patients who received tyrosine kinase inhibitors or immune checkpoint inhibitors as first‐line therapy.
Shuhei Kamada   +12 more
wiley   +1 more source

Inflammation, diabetic foot and related treatments. [PDF]

open access: yesFront Endocrinol (Lausanne)
Qin Y, Deng S.
europepmc   +1 more source

Immune dysregulation driven by elevated platelet-to-lymphocyte ratio aggravates myasthenia gravis. [PDF]

open access: yesJ Int Med Res
Luo S   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy